首页> 外文期刊>Mutation Research: International Journal on Mutagenesis, Chromosome Breakage and Related Subjects >Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer.
【24h】

Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer.

机译:在遗传性非息肉性结直肠癌家庭中,使用单个密码子缺失即可进行症状前诊断。

获取原文
获取原文并翻译 | 示例
       

摘要

The diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) is often confirmed by a mutation in one of several mismatch-repair genes, in particular MLH1, MSH2 and MSH6. Presymptomatic diagnosis requires the identification of a mutation causing the disease. Three different deletions of a single amino acid codon have previously been published as assumed pathogenic. The objective of this study was to determine if an MSH2 3 base pair in-frame deletion (N596del) could be used in presymptomatic screening of at-risk individuals. We report on five HNPCC families with the N596del mutation, identified after mutation screening of MSH2 and MLH1. All patients in the families were haplotyped using markers flanking the MSH2 gene. The haplotypes revealed that the five families with high probability descended from only two founders. The N596del segregated with the HNPCC phenotype with lod scores of 3.2 and 2.0 at the recombination fraction of 0.0 in the two founder families. Sequencing of MSH2 and MLH1 did not reveal other pathogenic mutations, and N596del was not identified in 50 healthy controls. The mutation has previously been found expressed in mRNA, and is located in a conserved domain. The results support the hypothesis that N596del is the disease causing mutation and not a clinically silent variation. On this basis, the application of the MSH2 N596del mutation, in presymptomatic screening of HNPCC families, is recommended.
机译:遗传性非息肉性大肠癌(HNPCC)的诊断通常通过几种失配修复基因之一,特别是MLH1,MSH2和MSH6的突变来证实。症状前诊断需要鉴定引起疾病的突变。单个氨基酸密码子的三个不同的缺失先前已被认为是致病的。这项研究的目的是确定是否可以将MSH2 3碱基对读框内缺失(N596del)用于危险个体的症状前筛查。我们报告了五个具有N596del突变的HNPCC家族,这些家族是在对MSH2和MLH1进行突变筛选后确定的。使用MSH2基因两侧的标记对家庭中的所有患者进行单倍型分析。单倍型显示五个家族的可能性很高,仅来自两个创始人。在两个创始人家族中,N596del与HNPCC表型分离,lod得分分别为3.2和2.0,重组率为0.0。 MSH2和MLH1的测序未显示其他致病突变,并且在50个健康对照中未鉴定到N596del。先前已经发现该突变在mRNA中表达,并且位于保守域中。结果支持以下假设:N596del是引起突变的疾病,而不是临床上沉默的变异。在此基础上,建议将MSH2 N596del突变应用于HNPCC家族的症状前筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号